Position in CYTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$14,029,769
+$4,075,977 QoQ
Shares Held
164,688
+9.0% QoQ
Ownership
0.118%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#105
of 477 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 67%
Shared 0%
None 33%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Legal & General Group Plc holds $3,286,710,193 across 292 Biotechnology names. CYTK ranks #35 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,870,015 | $928,892,550 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
759,971 | $473,872,316 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
924,561 | $278,320,596 | |
| 4 | RPRX |
Royalty Pharma plc
|
3,800,504 | $213,094,258 | |
| 5 | INCY |
Incyte Corp
|
1,605,980 | $182,053,892 | |
| 6 | ARGX |
Argenx SE
|
177,164 | $164,367,443 | |
| 7 | INSM |
INSMED Inc
|
826,431 | $88,114,072 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
381,366 | $71,422,223 |
All Filings in CYTK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,029,769 | 164,688 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $9,953,792 | 151,021 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $10,711,953 | 168,586 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $9,873,562 | 179,650 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $6,004,589 | 181,737 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $7,149,037 | 177,881 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $8,402,848 | 178,632 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $8,974,785 | 169,977 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $8,642,684 | 159,518 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $10,034,563 | 143,126 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $22,248,999 | 266,487 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $7,871,004 | 267,176 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $8,759,643 | 268,536 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $9,448,726 | 268,506 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $12,215,565 | 266,599 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $12,573,259 | 259,510 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $9,559,256 | 243,300 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $8,810,656 | 239,355 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $9,279,494 | 203,587 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $6,949,606 | 194,449 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,084,468 | 155,860 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $4,696,798 | 201,926 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $4,166,347 | 200,498 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $4,324,457 | 199,744 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $3,965,769 | 168,255 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,760,930 | 149,358 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||